In the present study, we investigated whether intestinal sterol efflux transporters Abcg5 and Abcg8 play a major role in determining variations in cholesterol absorption efficiency, and compared the physiological functions of the duodenal, jejunal, and ileal Abcg5 and Abcg8 on the absorption of cholesterol and sitostanol in inbred mice challenged with various amounts of cholesterol, sitostanol, hydrophilic or hydrophobic bile acids. We found that Abcg5 and Abcg8 in the jejunum and ileum, but not in the duodenum, were main determinants in determining, in part, variations in cholesterol absorption efficiency. The jejunal and ileal Abcg5 and Abcg8 played a major regulatory role in response to high dietary cholesterol and were more sensitive in the regulation of cholesterol absorption compared with sitostanol absorption. These results, combined with different sterol uptake rates, suggest that the absorption efficiency of cholesterol and sitostanol is determined by the net results between influx and efflux of intraluminal cholesterol and sitostanol molecules cross the apical membrane of the enterocyte. Hydrophilic and hydrophobic bile acids influenced cholesterol absorption through mediating cholesterol solubilization and its physical-chemical state within the small intestinal lumen. We conclude that cholesterol absorption is mainly regulated by the jejunal and ileal Abcg5 and Abcg8 in mice.
INTRODUCTION
The small intestine is a unique organ providing dietary and re-absorbed biliary cholesterol to the body, and plays a critical role in the regulation of whole body cholesterol balance (1, 2) . Because elevated plasma cholesterol concentrations is an important risk factor for cardiovascular diseases, intensive studies have been carried out to search for physical-chemical, biochemical and genetic determinants of intestinal cholesterol absorption. Recently, two independent groups (3,4) used a microarray analysis of mouse intestine and liver genes upregulated by a liver X receptor (LXR) agonist as well as a positional cloning approach to identify mutations in sitosterolemia patients in either member of an adjacent pair of genes, ABCG5 and ABCG8, encoding ATP-binding cassette (ABC) transporters expressed in the liver and intestine. By studying their function and expression in some "manufactured" mouse strains treated with or without LXR agonists (5-9), it has been proposed that ABCG5 and ABCG8 could promote efflux of cholesterol and sitosterol (plant sterol) from the enterocyte back into the intestinal lumen for elimination, and mediate biliary sterol secretion in the human.
Although a very large number of polymorphic variants in both Abcg5 and Abcg8 among 20 strains of inbred mice have been identified (10), none of these mice showed any detectable levels of plasma sitosterol under chow (containing ~0.01% sitosterol) diet conditions. Thus whether the polymorphisms at the Abcg5 and Abcg8 genes and their expression levels in the intestine are an important determinant of intestinal cholesterol absorption efficiency in healthy inbred mice remains to be investigated. Furthermore, the autosomal recessive disorder sitosterolemia (11-13) is mainly characterized by hyperabsorption of cholesterol and sitosterol, and reduced secretion of these sterols by guest, on www.jlr.org
Downloaded from
It has been reported that there are significant variations in cholesterol absorption efficiency, and genetic factors at enterocyte level may play a major role in determining intestinal cholesterol absorption efficiency in inbred mice (26-28). Despite it has been found that some dietary factors, biliary factors, enterocyte factors, and luminal factors could influence cholesterol absorption (1, 2) , it remains poorly understood which step (s) in the absorption process differ inherently among individuals in any population to explain variations in intestinal cholesterol absorption efficiency. In the present study, we studied hyodeoxycholic, and ursocholic (3α,7β,12α-trihydroxy-5β-cholan-24-oic) acids were purchased from Calbiochem-Behring (San Diego, CA), and α-, β-, and ω-muricholic acids were from Tokyo Tanabe (Tokyo, Japan). Grade I egg yolk lecithin was purchased from Lipid Products (Surry, UK). Medium-chain triglyceride was purchased from Mead
Johnson (Evansville, IN), and Intralipid (20%, wt/vol) was from Pharmacia (Clayton, NC).
Animals and diets. Male strains of inbred A/J (A), AKR/J (AKR), DBA/2J (DBA),
C57BL/6J (C57BL), C57L/J (C57L), and SWR/J (SWR) mice (6-8 wk old) were purchased from The Jackson Laboratory (Bar Harbor, ME). All animals were maintained in a temperature-controlled room (22±1°C) with a 12-h day cycle (6:00 AM-6:00 PM). 
Measurement of absorption and lymphatic transport of cholesterol and sitostanol.
After AKR and C57L mice (n=5 per group) were anesthetized with pentobarbital, laparotomy was performed under sterile conditions through an upper midline incision.
To exclude the effects of bile on intestinal absorption of cholesterol and sitostanol, a mouse model with a chronic biliary fistula was established according to published methods (29). To better expose the mesenteric lymphatic duct, the animal was dorsally arch-bridged over a 3-ml syringe. A PE-10 catheter was inserted into the mesenteric µl of medium-chain triglyceride containing 0.5% (wt/wt) taurocholate and 0.2% egg yolk lecithin were instilled into the small intestine through a duodenal catheter. Measurement of absorption and lymphatic transport of cholesterol and sitosterol was initiated, and fresh lymph was collected hourly into a heparinized tube for a total of 12 h (30). The two radioactive isotopes in the lymph were extracted and counted. To maintain lymph flow, a continuous intraduodenal infusion of 0.5% taurocholate and 0.2% egg yolk lecithin in medium-chain triglyceride was performed at 300 µl/h for 12 h. During surgery and lymph collection, mouse body temperature was maintained at 37±0.5°C with a heating lamp and monitored with a thermometer. Continuous anesthesia was maintained with an intraperitoneal injection of 25 mg/kg pentobarbital every 2 h. with the agents at 9:00 AM daily and harvested the intestine tissues for the extraction of total RNA at 10:00 AM. After the 7-day feeding, the mice were anesthetized with pentobarbital. The small intestine was removed, flushed with ice-cold saline solution, and cut into three segments with length ratios of 1:3:2 (duodenum:jejunum:ileum). In the middle of each intestinal segment, 1.5 cm of the duodenal, jejunal and ileal tissues were cut out, and the tissues from 4 mice per group were pooled. Total RNA was extracted from the intestine using RNeasy Midi (Qiagen, Valencia, CA). Reverse-transcription reaction was performed using the SuperScript II First-Strand Synthesis System (Invitrogen, Carlsbad, CA) with 5 µg of total RNA and random hexamers to generate cDNA. Primers and probes (Table 1) for Abcg5, Abcg8, Lxrα, and Lxrβ were designed using Primer Express Software (Applied Biosystems, Foster City, CA) based on sequence data available from GenBank. Real-time PCR assays (31) were performed in triplicate on a GeneAmp 5700 Sequence Detection System (Applied Biosystems).
Measurement of cholesterol absorption by fecal dual-isotope ratio method.
Relative mRNA levels were calculated using the threshold cycle (C T ) of an unknown sample against a standard curve with known copy numbers. To obtain a normalized target value, the target amount was divided by the endogenous reference rodent In contrast, expression levels of the jejunal and ileal Abcg5 and Abcg8 were the lowest in C57L and C57BL mice, with DBA and SWR mice showing intermediate values for
RESULTS

Absorption
Abcg5 and Abcg8 mRNA levels in the jejunum and ileum. We noted that the relative mRNA levels for the duodenal Abcg5 and Abcg8 were essentially similar in these mouse strains with different cholesterol absorption efficiency. Furthermore, our results demonstrate that there is a remarkably negative correlation between percent cholesterol absorption and expression levels of the jejunal and ileal Abcg5 and Abcg8 in chow-fed mice; however, they do not reach statistically significant differences.
Sterol uptake by the small intestine. To observe whether there are differences in uptake of cholesterol and sitostanol by the enterocyte, we compared their uptake rates in AKR and C57L mice. Our results ( Figure 3 ) show that at 45 min after dosing, the radiolabeled cholesterol and sitostanol uptake by the enterocytes of C57L mice was 1. Table 2 summaries the data for daily cholesterol intake, daily biliary cholesterol output, daily fecal total neutral steroid excretion, daily absorbed cholesterol, and percent cholesterol absorption in AKR and C57L mice in the metabolic steady state.
We found that the lower-absorbing AKR mice and the higher-absorbing C57L mice ate basically similar amounts of food, whatever chow or high dietary cholesterol was fed.
However, on the chow diet (0.02% cholesterol), daily biliary cholesterol outputs in C57L mice (2.11±0.08 mg/day) were significantly (P<0.0001) higher compared with AKR mice (1.14±0.08 mg/day) because C57L mice are a gallstone-susceptible strain (32).
Because of higher biliary cholesterol secretion, daily fecal total neutral steroid excretion was significantly (P<0.0001) greater in C57L mice (2.62±0.08 mg/day) than in AKR mice cholesterol. Taken together, these results suggest that C57L mice absorb more cholesterol than AKR mice, whatever chow or high dietary cholesterol is fed.
Because plant sterols have been used as cholesterol-lowering agents (33-35),
we examined their effects on intestinal cholesterol absorption. Our results (Table 3) show that AKR and C57L mice ate identical amounts of cholesterol although various amounts of sitostanol were fed. Sitostanol (≤1%) feeding did not cause significant changes in intestinal cholesterol absorption (percentage and total mass), biliary cholesterol outputs, and fecal steroid excretion. In contrast, increasing dietary sitostanol to 2% induced a significant increase in fecal total neutral steroid excretion (P<0.05), as well as significant decreases in biliary cholesterol outputs (P<0.001), absorbed cholesterol mass (P<0.01), and percent cholesterol absorption (P<0.05) in both strains of mice, favoring AKR mice more than C57L mice.
To further examine responses of intestinal sterol efflux transporters to high dietary cholesterol and sitostanol, we studied expression levels of Abcg5 and Abcg8 in AKR and C57L mice fed various amounts of cholesterol or sitostanol. Compared with the basal (0.02% cholesterol) diet, feeding 0.5% or higher dietary cholesterol significantly (P<0.01) increased expression levels of Abcg5 and Abcg8 in the jejunum and ileum, but not in the duodenum ( Figure 4A ), which is associated with increased fecal neutral steroid excretion (Table 2) . Our results suggest that in response to high (≥0.5%) dietary cholesterol, the jejunal and ileal Abcg5 and Abcg8 may efflux more cholesterol from the enterocyte back into the lumen and reduce its fractional absorption.
Furthermore, this kind of response was not observed in mice fed sitostanol until its concentration in the diet was increased to 2% ( Figure 4B ). This suggests that the Effect of bile acids on expression of intestinal sterol efflux transporters. Figure 6 shows expression levels of the Abcg5 and Abcg8 genes in the duodenum, jejunum, and ileum of AKR and C57L mice fed chow, or chow supplemented with 0.5% (by weight) bile acids for 7 days. Compared with the chow feeding, expression levels of Abcg5 and Abcg8 in the jejunum and ileum were essentially similar in mice fed the hydrophilic bile acids, but were increased significantly (P<0.001) by cholic acid feeding and to a lesser extent by deoxycholic and dehydrocholic acid feeding. In contrast, the relative mRNA levels for Abcg5 and Abcg8 in the duodenum were not influenced, whatever hydrophilic or hydrophobic bile acids were fed. Sitostanol is a saturated form of sitosterol, and both are structurally similar to cholesterol but differ in their side chain configuration (41) (42) (43) . In this study, using lymphatic sterol transport approaches in animals with a chronic biliary fistula but in the setting of infusion of the lipid emulsion, we observed that the higher-absorbing C57L mice displayed significantly higher cholesterol and sitostanol absorption rates than the lower-absorbing AKR mice. Our study also produced direct evidence demonstrating that at 12 h after instilling radiolabeled cholesterol and sitostanol, cumulative radioactivities of sitostanol (2-4%) in the lymph were significantly lower compared with those of cholesterol (22-36%) in both mouse strains. Furthermore, compared with the basal (0.02% cholesterol) diet, higher (≥0.5%) dietary cholesterol significantly increased by guest, on October 1, 2017
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Abcg5 and Abcg8 mRNAs levels in the jejunum and ileum, but not in the duodenum, favoring AKR mice more than C57L mice. Of note is that compared with C57L mice, AKR mice showed a significantly higher fecal total neutral steroid excretion (Table 2 ).
These data suggest that in response to high dietary cholesterol, the jejunal and ileal sterol transporters Abcg5 and Abcg8 may efflux more cholesterol from the enterocyte back into the lumen and reduce its fractional absorption in AKR mice than in C57L mice.
However, this kind of response was not observed in both strains of mice fed sitostanol until its concentration in the diet was increased to 2%, suggesting that there may be a selective regulatory mechanism between cholesterol and sitostanol absorption and the intestinal Abcg5 and Abcg8 may be more sensitive in the regulation of cholesterol absorption compared with sitostanol absorption. Our findings suggest that intestinal sterol efflux transporters Abcg5 and Abcg8 may provide a barrier to cholesterol and sitostanol accumulation by promoting partial efflux of cholesterol and nearly complete efflux of sitostanol from the enterocyte into the intestinal lumen for elimination.
The differences in cholesterol absorption efficiency among strains or individuals have been observed in animals (26-28,44-50) and humans (51) (52) (53) (54) . Recent studies (26-28) suggest that such variability could result from the interaction of multiple genes in the enterocyte. With inbred mouse models, we studied whether intestinal Abcg5 and Abcg8 influence the absorption of cholesterol under normal physiological conditions. We found that the relative mRNA levels for Abcg5 and Abcg8 in the jejunum and ileum were the highest in AKR and A strains with the lowest cholesterol absorption efficiency. In contrast, expression levels of Abcg5 and Abcg8 mRNAs in the jejunum and ileum were the lowest in C57L and C57BL strains with the highest cholesterol absorption efficiency. Moreover, expression levels of the duodenal Abcg5 and Abcg8 were essentially similar among these inbred mice with diverse cholesterol absorption efficiency, and were not influenced in mice challenged with various amounts of cholesterol, sitostanol, hydrophilic or hydrophobic bile acids. Especially, the sterol uptake studies showed that the duodenum and jejunum accumulated the most radioactivities following the administration of radiolabeled cholesterol and sitostanol, which is 1.5-fold higher in the higher-absorbing C57L mice than in the lower-absorbing AKR mice. More recently, Altmann and colleagues (55) found that disruption of the NPC1L1 gene encoding the Niemann-Pick C1 Like 1 protein induces a significant decrease in intestinal cholesterol absorption in mice. They (55) also observed that ezetimibe lowered cholesterol absorption by ~70% in the wild-type mice, and this level of cholesterol absorption was similar to that seen in NPC1L1 knockout mice not treated with ezetimibe. Thus, NPC1L1
was proposed to be a sterol influx transporter in the small intestine, which may be critical for intestinal uptake of sterols. Furthermore, the expression levels of NPC1L1
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www.jlr.org Downloaded from mRNA and protein are relatively higher in the proximal small intestine of rats and relatively lower in the distal small intestine (55) . Therefore, our results support the concept that the main sites of cholesterol absorption are the duodenum and proximal jejunum (56) (57) (58) (59) . It is important to note that in the chow-fed mouse, the expression levels of Abcg5 and Abcg8 in the duodenum and jejunum are somewhat greater compared with those in the ileum as measured by Northern blot analysis (3, 5, 24) . In this study, the relative mRNA levels for Abcg5 and Abcg8 are slightly higher in the jejunum and ileum than in the duodenum as assayed by our highly precise quantitative real-time PCR methods. A possible explanation for these differences is that other research groups (3,5,24) extracted total RNA from the entire intestinal mucosa of three segments with length ratios of 1:1:1 (duodenum:jejunum:ileum). We cut the small intestines into three segments with length ratios of 1:3:2 (duodenum:jejunum:ileum). Then, the middle 1.5 cm of intestinal tissue in each segment from 4 mice per group was pooled, which was used for total RNA extraction. Another reason is possibly due to different murine genetic backgrounds.
"Uptake of cholesterol" refers to entry of cholesterol into intestinal absorption cells (1,2). To investigate whether there are differences in intestinal uptake between cholesterol and sitostanol, we compared their uptake rates in AKR and C57L mice. Our results show that at 45 min after dosing, radiolabeled cholesterol and sitostanol uptake by the enterocytes of C57L mice was 1.5-fold higher compared with AKR mice.
Furthermore, the fact that cholesterol is absorbed more than structurally similar sitostanol in both strains of mice, suggests that there may be a selective uptake mechanism between cholesterol and sitostanol, and a cholesterol transporter(s) (55,60- by guest, on October 1, 2017
www.jlr.org Downloaded from 64) may be localized at the apical membrane that facilitates selective cholesterol but not sitostanol uptake by the enterocyte. It is important to note that the techniques used in the present study cannot determine the amounts of sterols that are re-secreted into the intestinal lumen by the Abcg5 and Abcg8 pathway. However, in the previous study of small intestinal transit in mice (26), we found that 30 min after the installation of radiolabeled sitostanol into the small intestine through the duodenal catheter, the radioactivity can be detected at the end of small intestine, i.e., in the ileum, but not in the cecum or large intestine. Accordingly, we arbitrarily define that within 45 min, the intestinal sterol uptake is a predominant event, and there is no or less efflux of sterols from the enterocyte back to the lumen. Furthermore, it is imperative to investigate whether the newly identified intestinal sterol influx transporter NPC1L1 (55) plays a critical role in determining cholesterol absorption efficiency and in regulating cholesterol and sitostanol absorption in healthy inbred mice.
To explore the role of "oxysterol-LXRα-ABCG5/G8 pathway" in the regulation of cholesterol absorption, we challenged mice with diets under conditions in which the Abcg8 mRNA levels in the jejunum and ileum. Our results demonstrate that there is a remarkably negative correlation between percent cholesterol absorption and expression levels of the jejunal and ileal Abcg5 and Abcg8 in chow-fed mice; however, they do not reach statistically significant differences. Of note is that relative mRNA levels are calculated using the threshold cycle of an unknown sample against a standard curve with known copy numbers. To obtain a normalized target value, the target amount is divided by the endogenous reference rodent Gapdh as the invariant control.
Furthermore, total RNA was extracted from the pooled intestine tissues (n=4 per group) and real-time PCR assays were performed in triplicate from the same sample. As a result, the error bars depict the technique variance rather than the biological variance. significantly (P<0.01) increases expression levels of Abcg5 and Abcg8 in the jejunum and ileum, but not in the duodenum, which is associated with increased fecal neutral steroid excretion (Table 2 ). These data suggest that the jejunal and ileal Abcg5 and Abcg8 may play a major regulatory role in cholesterol absorption. (B) However, this kind of response is not observed in mice fed sitostanol until its concentration in the diet is increased to 2%, suggesting that Abcg5 and Abcg8 may be more sensitive in regulating cholesterol absorption than sitostanol absorption. Because real-time PCR assays were carried out in triplicate from the same sample of the pooled intestine tissues (n=4 per group), the error bars represent the technique variance rather than the biological variance. LXRα α α α
